NFYC and liver cancer: Among the top activated TFs identified by both the M2Kb and the ChIP-Atlas regulons, five TFs (NFYC, RUVBL1, E2F1, HCFC1 and CREB1) have been classified as prognostic markers for lower patient survival in liver cancer ((53) and Figure 3B).